Heart & Homoeopathy In COVID 19

Dr. Tridibesh Tripathy, BHMS, Professor Byomakesh Tripathy, Professor Shankar Das, Professor Dharmendra Pratap Singh, Prof. Rakesh Dwivedi, Mohini Gautam, Dr. Umakant Prusty, Dr. Jeevan Krushna Pattanaik, Dr. Pramod Bihary Pradhan, Dr. S. N. Pandey, Dr. Sudhanshu Dixit, Ms. Sanskriti Tripathy, Mrs. Anjali Tripathy
{"title":"Heart & Homoeopathy In COVID 19","authors":"Dr. Tridibesh Tripathy, BHMS, Professor Byomakesh Tripathy, Professor Shankar Das, Professor Dharmendra Pratap Singh, Prof. Rakesh Dwivedi, Mohini Gautam, Dr. Umakant Prusty, Dr. Jeevan Krushna Pattanaik, Dr. Pramod Bihary Pradhan, Dr. S. N. Pandey, Dr. Sudhanshu Dixit, Ms. Sanskriti Tripathy, Mrs. Anjali Tripathy","doi":"10.58806/ijhmr.2024.v3i2n01","DOIUrl":null,"url":null,"abstract":"Recently, the Indian Council of Medical Research (ICMR) through studies confirmed that there is no link between the COVID-19 vaccines & heart issues. The larger issue is that there is an established link between COVID-19 disease & heart issues. The current article deals with the details of the process of COVID-19 & heart problems. The patho-physiology, symptoms pattern, epidemiology of the entire phenomenon is touched upon. To deal with the COVID related heart issues, the article proposes the integration of Homoeopathy of AYUSH. In the article, it details out a suggested treatment protocol based on homoeopathic therapeutics for COVID related heart issues. Taking into account the risk factors involved in these heart issues, the percentage of individuals who have high blood sugar & high blood pressure levels in India are considered at high risk. The related data from National Family Health Survey 5th round is cited to enumerate the risk involved at the national level. Finally, the article banks on the useful properties of homoeopathy. These are cost effectiveness, clinical effectiveness & zero side effects. The article also enumerates its role in the mass coverage at the national level.","PeriodicalId":423982,"journal":{"name":"International Journal Of Health & Medical Research","volume":"216 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal Of Health & Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58806/ijhmr.2024.v3i2n01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Recently, the Indian Council of Medical Research (ICMR) through studies confirmed that there is no link between the COVID-19 vaccines & heart issues. The larger issue is that there is an established link between COVID-19 disease & heart issues. The current article deals with the details of the process of COVID-19 & heart problems. The patho-physiology, symptoms pattern, epidemiology of the entire phenomenon is touched upon. To deal with the COVID related heart issues, the article proposes the integration of Homoeopathy of AYUSH. In the article, it details out a suggested treatment protocol based on homoeopathic therapeutics for COVID related heart issues. Taking into account the risk factors involved in these heart issues, the percentage of individuals who have high blood sugar & high blood pressure levels in India are considered at high risk. The related data from National Family Health Survey 5th round is cited to enumerate the risk involved at the national level. Finally, the article banks on the useful properties of homoeopathy. These are cost effectiveness, clinical effectiveness & zero side effects. The article also enumerates its role in the mass coverage at the national level.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID 19 中的心脏与顺势疗法
最近,印度医学研究委员会(ICMR)通过研究证实,COVID-19 疫苗与心脏问题之间没有联系。更重要的问题是,COVID-19 疾病与心脏问题之间存在既定联系。本文将详细介绍 COVID-19 与心脏问题之间的关系。文章涉及整个现象的病理生理学、症状模式和流行病学。为了解决与 COVID 相关的心脏问题,文章提出了整合 AYUSH 顺势疗法的建议。文章详细介绍了基于同种疗法治疗 COVID 相关心脏问题的建议治疗方案。考虑到这些心脏问题所涉及的风险因素,印度高血糖和高血压患者的比例被视为高危人群。文章引用了第五轮全国家庭健康调查的相关数据,列举了全国范围内的相关风险。最后,文章论述了同种疗法的有益特性。这些特性包括成本效益、临床效果和零副作用。文章还列举了同种疗法在全国大规模普及中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Gestational Syphilis In Santos/Sp: Epidemiologic Analysis From 2016 To 2022 A Risk Analysis Of Low Birth Weight Incidence In Gorontalo City Canine Fossa Abscess In Pediatric: Case Report Canine Fossa Abscess In Pediatric: Case Report Heart & Homoeopathy In COVID 19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1